Aquaconnect commits $4.5 million for aquaculture biologicals R&D

Q: How long will it take to read this news story?

The story "Aquaconnect commits $4.5 million for aquaculture biologicals R&amp;D" has 508 words across 20 sentences, which will take approximately 3 - 5 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Aquaconnect commits $4.5 million for aquaculture biologicals R&amp;D" was covered 16 hours ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 284 news stories per day. It's most recent story was published 2 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #27191815</li><li>URL: https://beamstart.com/news/aquaconnect-commits-45-million-for-17424773418881</li></ul>

Business Standard Logo Business Standard 16h ago

Aquaconnect commits $4.5 million for aquaculture biologicals R&D - Business Standard

Quick Summary:

This initiative reinforces the company’s mission to provide deep life sciences-backed, innovative shrimp and fish health and farm care solutions, further strengthening its integrated value chain strategy.

The company is also in talks with leading biotech firms in the EU and the US to leverage global research expertise and co-develop formulations tailored to Indian aquaculture conditions.

With a commitment of approximately $4.5 million, the company is setting up a state-of-the-art R&D and production facility to drive innovation in aquaculture formulations.